Patents by Inventor David C. Soler

David C. Soler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of detecting cancer
    Patent number: 10066020
    Abstract: A method of detecting the presence of glioblastomas and/or recurrent glioblastomas in a subject in need thereof includes isolating CD14+ cells from a blood sample of the subject and determining the ratio of isolated CD14+ cells expressing low levels of HLA-DR to isolated CD14+ cells expressing VNN2, wherein the subject has increased risk of glioblastomas or recurrent glioblastoma if the ratio of isolated CD14+ cells expressing low levels of HLA-DR to isolated CD14+ cells expressing VNN2 is greater than about 2.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: September 4, 2018
    Assignee: Case Western Reserve University
    Inventors: David C. Soler, Andrew E. Sloan, Kevin D. Cooper, Thomas S. McCormick, Andrew B. Young
  • METHODS OF DETECTING CANCER
    Publication number: 20180030145
    Abstract: A method of detecting the presence of glioblastomas and/or recurrent glioblastomas in a subject in need thereof includes isolating CD14+ cells from a blood sample of the subject and determining the ratio of isolated CD14+ cells expressing low levels of HLA-DR to isolated CD14+ cells expressing VNN2, wherein the subject has increased risk of glioblastomas or recurrent glioblastoma if the ratio of isolated CD14+ cells expressing low levels of HLA-DR to isolated CD14+ cells expressing VNN2 is greater than about 2.
    Type: Application
    Filed: July 28, 2017
    Publication date: February 1, 2018
    Inventors: David C. Soler, Andrew E. Sloan, Kevin D. Cooper, Thomas S. McCormick, Andrew B. Young